What is the main business of Calyx Medical?

The main business activity of Calyx Medical focuses on manufacture of medical and dental instruments and supplies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 1, 2018.

Where is the headquarters located?

The headquarters is located at: ul. Wielka 31, 53-338 Wrocław.

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

What was the revenue?

The company reported a revenue of $654,639 in 2023, which is an increase of 45.5% compared to 2022.

Yes, the company recorded a net profit of $325,768 in 2023, meaning the company increased its profit by 167.9%.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $100,434 in 2023, representing 34% of all operating expenses.

Calyx Medicalsp. z o.o.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-10-01

Share capital

50,000.00 PLN

Registered address

ul. Wielka 31/2, 53-338 Wrocław, Poland

Electronic delivery address

AE:PL-75795-32380-DTUEF-33

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 4 of 5 financial statements were filed late (the longest delay 353 days for 2022).

2024not filed
202316/07/2024
202202/07/2024
202126/06/2023
202004/05/2022
201915/05/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.

Industry · Manufacture of medical and dental instruments and supplies185 / 495

Top 37%

Division · Other manufacturing185 / 495

Top 37%

Sector · Manufacturing5,452 / 12,010

Top 45%

Voivodeship · Dolnośląskie11,606 / 41,331

Top 28%

Country · Poland148,561 / 495,850

Top 30%

Results vs industry

Revenue

This companyUSD 654.64kMedianUSD 287.80kAverageUSD 4.91m

Net profit

This companyUSD 325.77kMedianUSD 12.59kAverageUSD 208.04k

Operating costs

This companyUSD 293.45kMedianUSD 272.78kAverageUSD 4.49m

Assets

This companyUSD 893.78kMedianUSD 224.38kAverageUSD 5.76m

Industry

Authorized Representatives

Paweł Andrzej Wiśniewski – Management Board Member

Kira Katarzyna Wiśniewska – President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Kira Katarzyna Wiśniewskaage 66	50	$6,753.11	50%
Paweł Andrzej Wiśniewskiage 65	50	$6,753.11	50%

Kira Katarzyna Wiśniewska and Paweł Andrzej Wiśniewski hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Subsidiaries

	Name	Share value	Stake
	Wismed Groupsp. z o.o.	1,350.62 USD	50%

Bank accounts

Registered as a VAT taxpayer on 2023-06-15.

Erste Bank Polska
23 1090 2529 0000 0001 3752 0362
Erste Bank Polska
50 1090 2529 0000 0001 3752 0361
Erste Bank Polska
58 1090 2529 0000 0001 3752 0411

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $1,773,330.

Grant date	Purpose	Gross amount	Granting body
Sep 24, 2021	Aid for research and development projects: industrial research	$1.1M$1,056,330	Dyrektor Narodowego Centrum Badań i Rozwoju
Sep 24, 2021	Aid for research and development projects: experimental development	$343.3K$343,330	Dyrektor Narodowego Centrum Badań i Rozwoju
Sep 24, 2021	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$115.1K$115,063	Dyrektor Narodowego Centrum Badań i Rozwoju

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
InmedS.A.	$13,860,648.96	inmed.pl
Zakład Optyczny Oculussp. z o.o.	$332,546.80	oculus.com.pl
Platinumsp. z o.o.	$313,097.87	platinum-klinika.pl
Markdentsp. z o.o.	$129,752.97	mark-dent.pl
K&J Polskasp. z o.o.	$70,953.51	kjpolska.pl
Hemolens Diagnosticssp. z o.o.	$37,964.68	hemolens.com
Pragma System Globalsp. z o.o.	$34,880.66	pragma.systems
Selex Polskasp. z o.o.	$7,765.44	selexpolska.com
Hetaloxsp. z o.o.	$965.71	hetalox.com
Spinetime Solutionssp. z o.o.	–	spinetime.eu